REN and chronic kidney disease: These studies have allowed to uncover the efficacy of drugs interfering with the Renin-Angiotensin-Aldosterone system, namely the Renin-Angiotensin-Aldosterone system inhibitors (RAASi), in relenting CKD progression and conferring CV protection to diabetic CKD patients (11, 12).